Ausgabe 6/2016
Inhalt (26 Artikel)
Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer
Frederik A. Verburg, Cumali Aktolun, Arturo Chiti, Savvas Frangos, Luca Giovanella, Martha Hoffmann, Ioannis Iakovou, Jasna Mihailovic, Bernd J. Krause, Werner Langsteger, Markus Luster
Evaluation of 124I PET/CT and 124I PET/MRI in the management of patients with differentiated thyroid cancer
Laurent Dercle, Désirée Deandreis, Marie Terroir, Sophie Leboulleux, Jean Lumbroso, Martin Schlumberger
Imaging with 124I in differentiated thyroid carcinoma: is PET/MRI superior to PET/CT?
I. Binse, T. D. Poeppel, M. Ruhlmann, B. Gomez, L. Umutlu, A. Bockisch, S. J. Rosenbaum-Krumme
Molecular imaging with 99mTc-MIBI and molecular testing for mutations in differentiating benign from malignant follicular neoplasm: a prospective comparison
L. Giovanella, A. Campenni, G. Treglia, F. A. Verburg, P. Trimboli, L. Ceriani, M. Bongiovanni
18F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma
Aurélien Archier, Céline Heimburger, Carole Guerin, Isabelle Morange, Fausto F Palazzo, Jean-François Henry, Olivier Schneegans, Olivier Mundler, Ahmad Esmaeel Abdullah, Frédéric Sebag, Alessio Imperiale, David Taïeb
Noninferior response in BRAFV600E mutant nonmetastatic papillary thyroid carcinoma to radioiodine therapy
Jiao Li, Jun Liang, Teng Zhao, Yansong Lin
Peptide receptor radionuclide therapy with 177Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and 18F-FDG PET
Annarita Ianniello, Maddalena Sansovini, Stefano Severi, Silvia Nicolini, Chiara Maria Grana, Katrin Massri, Alberto Bongiovanni, Lorenzo Antonuzzo, Valentina Di Iorio, Anna Sarnelli, Paola Caroli, Manuela Monti, Emanuela Scarpi, Giovanni Paganelli
Pilot prospective evaluation of 18F-FPPRGD2 PET/CT in patients with cervical and ovarian cancer
Ryogo Minamimoto, Amer Karam, Mehran Jamali, Amir Barkhodari, Sanjiv Sam Gambhir, Oliver Dorigo, Andrei Iagaru
Is dopamine transporter invariably impaired at the time of diagnosis in dementia with Lewy bodies?
Flavio Nobili, Dario Arnaldi, Silvia Morbelli
[123]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies
J. J. van der Zande, J. Booij, P. Scheltens, P. G. H. M. Raijmakers, A. W. Lemstra
Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: 18F-florbetapir (AV-45/Amyvid) PET study
Kuan-Yi Wu, Chia-Yih Liu, Cheng-Sheng Chen, Chia-Hsiang Chen, Ing-Tsung Hsiao, Chia-Ju Hsieh, Chin-Pang Lee, Tzu-Chen Yen, Kun-Ju Lin
Evaluation of software tools for automated identification of neuroanatomical structures in quantitative β-amyloid PET imaging to diagnose Alzheimer’s disease
Tobias Tuszynski, Michael Rullmann, Julia Luthardt, Daniel Butzke, Solveig Tiepolt, Hermann-Josef Gertz, Swen Hesse, Anita Seese, Donald Lobsien, Osama Sabri, Henryk Barthel
Amyloid-independent functional neural correlates of episodic memory in amnestic mild cognitive impairment
Eun Hyun Seo, IL Han Choo
Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [11C] DASB positron emission tomography study
Swen Hesse, Michael Rullmann, Julia Luthardt, Karsten Winter, Mohammed K. Hankir, Georg-Alexander Becker, Franziska Zientek, Georg Reissig, Ralf Regenthal, Mandy Drabe, Christian Schinke, Anke Bresch, Katrin Arelin, Donald Lobsien, Marianne Patt, Philipp M. Meyer, Mathias Fasshauer, Wiebke K. Fenske, Matthias Blüher, Michael Stumvoll, Osama Sabri
Early static 18F-FET-PET scans have a higher accuracy for glioma grading than the standard 20–40 min scans
Nathalie L. Albert, Isabel Winkelmann, Bogdana Suchorska, Vera Wenter, Christine Schmid-Tannwald, Erik Mille, Andrei Todica, Matthias Brendel, Jörg-Christian Tonn, Peter Bartenstein, Christian la Fougère
Reproducibility of O-(2-18F-fluoroethyl)-L-tyrosine uptake kinetics in brain tumors and influence of corticoid therapy: an experimental study in rat gliomas
Carina Stegmayr, Michael Schöneck, Dennis Oliveira, Antje Willuweit, Christian Filss, Norbert Galldiks, N. Jon Shah, Heinz H. Coenen, Karl-Josef Langen
In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis
Abraham Martín, Nuria Vázquez-Villoldo, Vanessa Gómez-Vallejo, Daniel Padro, Federico N. Soria, Boguslaw Szczupak, Sandra Plaza-García, Ander Arrieta, Torsten Reese, Jordi Llop, Maria Domercq, Carlos Matute
Tau imaging in neurodegenerative diseases
M. Dani, D. J. Brooks, P. Edison
Metabotropic glutamate receptor 5 – a promising target in drug development and neuroimaging
Rajapillai L. I. Pillai, Dnyanesh N. Tipre
Current status of PET imaging in Huntington’s disease
Gennaro Pagano, Flavia Niccolini, Marios Politis
Imaging of differentiated thyroid carcinoma: 124I-PET/MRI may not be superior to 124I-PET/CT
A. Vrachimis, M. Weckesser, M. Schäfers, L. Stegger
Imaging of differentiated thyroid carcinoma: 124I-PET/MRI may not be superior to 124I-PET/CT
Ina Binse, Sandra Julia Rosenbaum-Krumme, Andreas Bockisch
18F-DOPA: the versatile radiopharmaceutical
David Taïeb, Alessio Imperiale, Karel Pacak
Rudy A.J.O. Dierckx, Andreas Otte, Erik F.J. de Vries, Aren van Waarde (eds); guest editor Klaus L. Leenders: PET and SPECT in Neurology
Christian Marsiglia, Luigi Mansi
Mauro Papotti and Wouter W. De Herder (ed): Neuroendocrine Tumors: A Multidisciplinary Approach
Roberto Vignapiano, Luigi Mansi
The Pathophysiologic Basis of Nuclear Medicine, Third Edition, Abdelhamid H. Elgazzar, Ed.
Alessia Ruggiero, Luigi Mansi